作者: Giuseppe Alvaro , Charles Large
DOI:
关键词:
摘要: The present invention relates to pharmaceutical compositions comprising the NK1 receptor antagonist [2-Methoxy-5-(5-trifluoromethyl-tetrazol-1-yl)-benzyl]-(2S-phenyl-piperidin-3S-yl)-amine, or a pharmaceutically acceptable salt solvate thereof, and sodium channel blocker, as combined preparation for simultaneous sequential administration use of such in treatment certain disorders, including epilepsy, mood disorders pain.